1. Evaluation of a Platinum–Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma. (22nd October 2020) Authors: Ding, Song; Hackett, Christopher L.; Liu, Fang; Hackett, Ryan G.; Bierbach, Ulrich Journal: ChemMedChem Issue: Volume 16:Number 2(2021) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of a Platinum–Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma. (22nd October 2020) Authors: Ding, Song; Hackett, Christopher L.; Liu, Fang; Hackett, Ryan G.; Bierbach, Ulrich Journal: ChemMedChem Issue: Volume 16:Number 2(2021) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Large‐Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum–Acridine Anticancer Agent. Issue 14 (14th February 2017) Authors: Zheng, Ye; Fahrenholtz, Cale D.; Hackett, Christopher L.; Ding, Song; Day, Cynthia S.; Dhall, Rohan; Marrs, Glen S.; Gross, Michael D.; Singh, Ravi; Bierbach, Ulrich Journal: Chemistry Issue: Volume 23:Issue 14(2017) Page Start: 3386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗